3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Motor Activity
22
Neoplasms
13
Breast Neoplasms
9
Lung Neoplasms
6
Pancreatic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Peripheral Nervous System Diseases
2
Obesity
2
Neoplasm Metastasis
2
Lymphoma
2
Lymphedema
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcopenia
1
Rectal Neoplasms
1
Quality of Life
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Neurotoxicity Syndromes
1
Neurocognitive Disorders
1
Neoplasms, Plasma Cell
1
Muscular Atrophy
1
Multiple Myeloma
1
Interventions
pembrolizumab
9
Nivolumab
7
cemiplimab
6
Ipilimumab
6
Blood Specimen Collection
3
lifileucel
2
encorafenib
2
binimetinib
2
aldesleukin
2
Niacinamide
2
Cyclophosphamide
2
toripalimab
1
tislelizumab
1
relatlimab
1
oxycodone-acetaminophen
1
lenvatinib
1
lavender oil
1
fludarabine
1
epacadostat
1
durvalumab
1
dostarlimab
1
brodalumab
1
avelumab
1
atezolizumab
1
Water
1
Vitamin A
1
Tissue Banks
1
Surgical Procedures, Operative
1
Sunscreening Agents
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Exercise
×
90 days
×
Clear all
NCT06694571
2026-04-03
STARS
University of Utah
Phase NA
Completed
38 enrolled
9 charts